Creative Biolabs provides comprehensive antiviral drug discovery and testing services, covering the entire process from hits screening to drug production. Our team has extensive drug discovery experience and an in-depth understanding of virology, providing reliable solutions to assist clients in antiviral drug discovery.
We are capable of hit characterization to assess the efficacy and toxicity of possible non-pharmaceutical grade pharmaceuticals against anti-DNA or anti-RNA viruses. Observations and evaluations are conducted using high-throughput screening techniques to accurately predict the performance of non-pharmaceutical-grade drugs in trials and to delve into the mechanisms underlying the pharmacological effects of antiviral drugs and their interactions with viruses in the host. We carry out this work using the most rigorous biochemistry, molecular biology and cell biology techniques and methods.
The common subtypes of viruses that trigger infections are classified by nucleic acid type into DNA and RNA types, and can be further subdivided into double-stranded, single-stranded, and retroviruses. Our non-pharmaceutical grade drug development services include infection investigations with several common viral subtypes. Our team offers extensive expertise and technological capabilities ranging from the identification of viral targets to the screening and optimization of therapeutic candidates.
Our research-grade virus technical services are focused on the design, synthesis and production of a broad group of viruses, including pseudoviruses, virus-like particles and recombinant viral proteins, for drug screening and research. In the meantime, powerful sequencing and analysis tools ensure that viruses are delivered with a high degree of reliability and validity.
Creative Biolabs is dedicated to providing non-pharmaceutical grade active compound screening and viral inhibitor drug discovery services to help clients better study and understand the mechanisms of different viral infections. We provide efficient, rapid, and customized solutions to support your research and drug discovery goals. Please contact us for further information.
